References

[1] National Cancer Institute. (2016). Gallbladder Cancer - Patient Version. Retrieved from

https://www.cancer.gov/types/gallbladder

[2] Creasy, J.M., Goldman, D.A., Dudeja, V., Lowery, M.A., Cercek, A., Balachandran, V.P.,

Jarnagin, W.R. (2017). Systemic Chemotherapy Combined with Resection for Locally

Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. American College of

Surgeons, 224 (5), 906-916.

doi: http://dx.doi.org/10.1016/j.jamcollsurg.2016.12.058

[3] Lazcano-Ponce, E. C., Miquel, J. F., Muoz, N., Herrero, R., Ferrecio, C., Wistuba, I. I., Nervi,

F. (2001). Epidemiology and molecular pathology of gallbladder cancer. CA: A Cancer

Journal for Clinicians, 51 (6), 349-364.

doi: 10.3322/canjclin.51.6.349

[4] Lewis, S. M., Dirksen, S., Heitkemper, M., Bucher, L., & Camera, I. (2014). Medical-surgical

nursing in Canada: Assessment and management of clinical problems. (3rd ed.). M.A. Barry,

S. Goldsworthy & D. Goodridge (Ed.). Toronto, ON: Elsevier Mosby.

[5] Hundal, R., & Shaffer, E. A. (2014) Gallbladder cancer: Epidemiology and outcome. Clinical

Epidemiology, 6, 99-109.

[6] Bal, M. M., Ramadwar, M., Deodhar, K., & Shrikhande, S. (2015). Pathology of gallbladder

carcinoma: Current understand and new perspective. Pathology & Oncology Research, 21,

509-525.

doi: 10.1007/s12253-014-9886-3

[7] Rustagi, T. & Dasanu, C. A. (2012). Risk factors for gallbladder cancer and cholangiocarcinoma:

Similarities, differences and updates. Journal of Gastrointestinal Cancer, 43, 137-147.

 doi: 10.1007/s12029-011-9284-y

[8] Espinoza, J. A., Bizama, C., Garcia, P., Ferreccio, C., Javle, M., Miquel, J. F., Roa, J. C.

(2016) The inflammatory inception of gallbladder cancer. Biochema et Biophysica Acta

1865, 245-254.

http://dx.doi.org/10.1016/j.bbcan.2016.03.004

[9] Canadian Cancer Society. (2017). Risk factors for gallbladder cancer. Retrieved from

http://www.cancer.ca/en/cancer-information/cancer-type/gallbladder/risks/?region=bc

[10] Fuller, K. (2014). Diagnosing Gallbladder Cancer. Journal for Nurse Practitioners, 10 (10),

868-869.

doi: http://dx.doi.org/10.1016/j.nurpra.2014.08.007

[11] American Cancer Society. (2017). Gallbladder Cancer. Retrieved from

https://www.cancer.org/cancer/gallbladder-cancer.html

[12] Denshaw-Burke, M., Kennedy, A. S., & Katz, J. (2014). Gallbladder cancer medication. In F.

Talavera, B. Movsas, & N. J. Espat (Eds.), Medscape (Drugs & Diseases - Oncology).

Retrieved from http://emedicine.medscape.com/article/278641-medication#2

[13] Oxaliplatin: Drug information. (2017). In UpToDate. Retrieved from https://www-uptodate-

com.myaccess.library.utoronto.ca/contents/oxaliplatin-drug-information?

source=preview&search=oxaliplatin&anchor=F204234#F204234

[14] Lehne, R. A. (2016). Lehnes Pharmacology for Nursing Care (9th ed.). St. Louis: Elsevier

Saunders.

[15] Denshaw-Burke, M., Kennedy, A. S., & Katz, J. (2014). Gallbladder cancer treatment &

management. In F. Talavera, B. Movsas, & N. J. Espat (Eds.), Medscape (Drugs & Diseases -

Oncology). Retrieved from http://emedicine.medscape.com/article/278641-treatment

[16] Mayo Clinic. (2014). Diseases and conditions: Gallbladder cancer. Retrieved from

http://www.mayoclinic.org/diseases-conditions/gallbladder- cancer/basics/treatment/con-

20023909

[17] Cancer Research UK. (2014). Pain Control for Advanced Gallbladder Cancer. Retrieved from

http://www.cancerresearchuk.org/about-cancer/type/gallbladder-

cancer/treatment/advanced/pain-control-for-advanced-gallbladder-cancer